CA2070114A1 - A method of treating hyperglycemia - Google Patents

A method of treating hyperglycemia

Info

Publication number
CA2070114A1
CA2070114A1 CA 2070114 CA2070114A CA2070114A1 CA 2070114 A1 CA2070114 A1 CA 2070114A1 CA 2070114 CA2070114 CA 2070114 CA 2070114 A CA2070114 A CA 2070114A CA 2070114 A1 CA2070114 A1 CA 2070114A1
Authority
CA
Canada
Prior art keywords
treating hyperglycemia
treating
hyperglyoemia
anxiety
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2070114
Other languages
French (fr)
Other versions
CA2070114C (en
Inventor
Yukihiko Hara
Fumiko Tono-Oka
Akiyo Ishigaki
Natsuki Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Norin Co Ltd
Original Assignee
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Norin Co Ltd filed Critical Mitsui Norin Co Ltd
Priority to CA 2070114 priority Critical patent/CA2070114C/en
Publication of CA2070114A1 publication Critical patent/CA2070114A1/en
Application granted granted Critical
Publication of CA2070114C publication Critical patent/CA2070114C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method of treating hyperglyoemia, comprising administering to a patient in need thereof, an effective amount of tea polyphenol. Anti-hyperglycemic agent of this invention is free from anxiety about harmful side effects to human bodies.
CA 2070114 1992-06-01 1992-06-01 A method of treating hyperglycemia Expired - Fee Related CA2070114C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2070114 CA2070114C (en) 1992-06-01 1992-06-01 A method of treating hyperglycemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2070114 CA2070114C (en) 1992-06-01 1992-06-01 A method of treating hyperglycemia

Publications (2)

Publication Number Publication Date
CA2070114A1 true CA2070114A1 (en) 1993-12-02
CA2070114C CA2070114C (en) 2002-08-20

Family

ID=4149943

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2070114 Expired - Fee Related CA2070114C (en) 1992-06-01 1992-06-01 A method of treating hyperglycemia

Country Status (1)

Country Link
CA (1) CA2070114C (en)

Also Published As

Publication number Publication date
CA2070114C (en) 2002-08-20

Similar Documents

Publication Publication Date Title
MY121276A (en) Use of glp-1 or analogs to abolish catabolic changes after surgery
AU8138687A (en) Agents for combating pests and plant treatment agents
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
ZA906883B (en) A method of treating premature ejaculation using sertraline
HUT63163A (en) Process for producing anxiety relieving bis-azabicyclo compounds and pharmaceutical compositions comprising same as active ingredient
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
CA2061270A1 (en) Method and Composition for Treating Reperfusion Injury
CA2139385A1 (en) Products containing g-csf and tnf binding protein
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
CA2294207A1 (en) Anti-chlamydia agent
EP0744176A3 (en) Methods for inhibiting bone loss
HUT61199A (en) Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
CA2070114A1 (en) A method of treating hyperglycemia
IE870577L (en) Topical amide preparation
HU9301217D0 (en) Antiseptic active agent of herb extract and method for obtaining it
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
NZ268039A (en) Use of efaroxan in treating parkinson's disease
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
MD950010A (en) Composition for removing or deactivation of toxic components from blood and other extracellular body liquids and methol for prepations theref
PL326558A1 (en) Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy
EP0436717A4 (en) Method of treatment with medical agents
CA2237643A1 (en) Therapeutic agent for acute hepatic failure
CA2103708A1 (en) Treatment of ovarian cancer
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed